Pharmacogenomic Product Development
By understanding the cause of spinal diseases on the molecular level, Axial Biotech has been able to begin research on understanding the chemical pathways that ultimately lead to disease progression. Under the leadership of our team of geneticists, this research has now extended into looking at potential biological or pharmacological solutions to these diseases.
